Collegium Pharmaceutical, Inc. (COLL) earnings
COLL earnings moved a median of +0.42% by the close. Quarterly and annual COLL reports and results, each read against the price at its own news timestamp. Back to the COLL overview →
30 measured COLL earnings events.
Where these COLL earnings landedvs 30 measured COLL earnings reactions
| Middle 50% of COLL earnings reactions | -2.89% to +2.69% |
|---|---|
| Median reaction (to close) | +0.42% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 COLL earnings events with a measured close landed between -2.89% and +2.69%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress | Press release | +2.58% | -6.16% | |
| Form 10-Q COLLEGIUM PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | +2.58% | -6.16% | |
| Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | -0.90% | +3.70% | |
| Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress | Press release | -2.82% | +5.58% | |
| Form 10-Q COLLEGIUM PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -2.82% | +5.58% | |
| Collegium to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | +1.26% | -2.74% | |
| Form 10-K COLLEGIUM PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-K | -0.33% | +5.92% | |
| Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance | Press release | -0.65% | +1.02% | |
| Form 10-Q COLLEGIUM PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | -0.65% | +1.02% | |
| Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025 | Press release | +0.62% | -0.17% | |
| Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook | Press release | +4.57% | +4.64% | |
| Form 10-Q COLLEGIUM PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | +4.57% | +4.64% | |
| Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | +0.25% | -1.08% | |
| Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress | Press release | -5.16% | -2.60% | |
| Form 10-Q COLLEGIUM PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -5.16% | -2.60% | |
| Collegium to Report First Quarter 2025 Financial Results on May 8, 2025 | Press release | +0.84% | +2.72% | |
| Form 10-K COLLEGIUM PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-K | +1.55% | -4.22% | |
| Collegium Reports Record Third Quarter 2024 Financial Results | Press release | -0.24% | -2.60% | |
| Form 10-Q COLLEGIUM PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | -0.24% | -2.60% | |
| Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024 | Press release | +0.61% | -4.40% | |
| Collegium Reports Second Quarter 2024 Financial Results | Press release | +0.55% | +2.57% | |
| Form 10-Q COLLEGIUM PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | +0.55% | +2.57% | |
| Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024 | Press release | -0.46% | +2.46% | |
| Collegium Reports First Quarter 2024 Financial Results | Press release | -2.47% | -4.57% | |
| Form 10-Q COLLEGIUM PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -2.47% | -4.57% | |
| Collegium to Report First Quarter 2024 Financial Results on May 9, 2024 | Press release | +0.13% | +1.33% | |
| Form 10-K COLLEGIUM PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-K | -0.25% | +5.36% | |
| Collegium Reports Third Quarter 2023 Financial Results | Press release | -1.26% | -2.94% | |
| Form 10-Q COLLEGIUM PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | -1.26% | -2.94% | |
| Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023 | Press release | +0.26% | +1.87% |
Keep exploring
More COLL: analyst actions → · SEC filings → · COLL overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MYOS RENS TECH INC COMMON (MYOS) | 334 | 0.00% | 43% |
| Actelis Networks, Inc. (ASNS) | 331 | -0.83% | 36% |
| BG MEDICINE INC (BGMD) | 329 | 0.00% | 39% |
| IQVIA Holdings, Inc. (IQV) | 329 | +0.02% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.